Wednesday, October 5, 2011

Molecular Therapy - Table of Contents alert Volume 19 Issue 10

TABLE OF CONTENTS

Volume 19, Issue 10 (October 2011)

In this issue
Editorial
In This Issue
Research Highlights
Commentaries
Reviews
Original Articles

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
New to NPG: Molecular Therapy-Nucleic Acids
Online. Open Access. High-Quality Research.

Molecular Therapy-Nucleic Acids is a sibling journal to the well-established high impact journal, Molecular Therapy. The journal will publish high quality basic, translational, and clinical research and cuttingedge reviews and commentaries targeted to the advances in oligonucleotide- and gene-based therapies. Molecular Therapy-Nucleic Acids is a peer-reviewed, fully open access, online journal. Molecular Therapy-Nucleic Acids is published on behalf of the American Society of Gene & Cell Therapy and NPG.

Sign up today for a Molecular Therapy-Nucleic Acids alert.
 

Editorial

Top

Cell Phones and Landlines: The Impact of Gene Therapy on the Cost and Availability of Treatment for Hemophilia

Katherine A High and Mark W Skinner

Mol Ther 2011 19: 1749-1750; 10.1038/mt.2011.203

Full Text

In This Issue

Top

In This Issue

Mol Ther 2011 19: 1752; 10.1038/mt.2011.199

Full Text

Research Highlights

Top

Research Highlights

Mol Ther 2011 19: 1753; 10.1038/mt.2011.200

Full Text

Commentaries

Top

Intranasal Exosomes for Treatment of Neuroinflammation?: Prospects and Limitations

Samira Lakhal and Matthew JA Wood

Mol Ther 2011 19: 1754-1756; 10.1038/mt.2011.198

Full Text

Bridge Over Troubled stem cells

Grant A Challen and Margaret A Goodell

Mol Ther 2011 19: 1756-1758; 10.1038/mt.2011.184

Full Text

Reviews

Top

Insulin-producing Surrogate β-cells From Embryonic Stem Cells: Are We There Yet?

Ortwin Naujok, Chris Burns, Peter M Jones and Sigurd Lenzen

Mol Ther 2011 19: 1759-1768; advance online publication, August 9, 2011; 10.1038/mt.2011.165

Abstract | Full Text

Original Articles

Top

Treatment of Brain Inflammatory Diseases by Delivering Exosome Encapsulated Anti-inflammatory Drugs From the Nasal Region to the Brain

Xiaoying Zhuang, Xiaoyu Xiang, William Grizzle, Dongmei Sun, Shuangqin Zhang, Robert C Axtell, Songwen Ju, Jiangyao Mu, Lifeng Zhang, Lawrence Steinman, Donald Miller and Huang-Ge Zhang

Mol Ther 2011 19: 1769-1779; advance online publication, September 13, 2011; 10.1038/mt.2011.164

Abstract | Full Text

Perturbing PSD-95 Interactions With NR2B-subtype Receptors Attenuates Spinal Nociceptive Plasticity and Neuropathic Pain

Richard D'Mello, Fabien Marchand, Sophie Pezet, Stephen B McMahon and Anthony H Dickenson

Mol Ther 2011 19: 1780-1792; advance online publication, March 22, 2011; 10.1038/mt.2011.42

Abstract | Full Text

Combined Flt3L/TK Gene Therapy Induces Immunological Surveillance Which Mediates an Immune Response Against a Surrogate Brain Tumor Neoantigen

Gwendalyn D King, AKM Ghulam Muhammad, Daniel Larocque, Kyle R Kelson, Weidong Xiong, Chunyan Liu, Nicholas SR Sanderson, Kurt M Kroeger, Maria G Castro and Pedro R Lowenstein

Mol Ther 2011 19: 1793-1801; advance online publication, April 19, 2011; 10.1038/mt.2011.77

Abstract | Full Text

Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy

Timothy Kottke, John Chester, Elizabeth Ilett, Jill Thompson, Rosa Diaz, Matt Coffey, Peter Selby, Gerard Nuovo, Jose Pulido, Debabrata Mukhopadhyay, Hardev Pandha, Kevin Harrington, Alan Melcher and Richard Vile

Mol Ther 2011 19: 1802-1812; advance online publication, July 26, 2011; 10.1038/mt.2011.147

Abstract | Full Text

Envelope-chimeric Entry-targeted Measles Virus Escapes Neutralization and Achieves Oncolysis

Tanner S Miest, Koon-Chu Yaiw, Marie Frenzke, Johanna Lampe, Andrew W Hudacek, Christoph Springfeld, Veronika von Messling, Guy Ungerechts and Roberto Cattaneo

Mol Ther 2011 19: 1813-1820; advance online publication, May 24, 2011; 10.1038/mt.2011.92

Abstract | Full Text

Age-dependent Dystrophin Loss and Genetic Reconstitution Establish a Molecular Link Between Dystrophin and Heart Performance During Aging

DeWayne Townsend, Michael Daly, Jeffrey S Chamberlain and Joseph M Metzger

Mol Ther 2011 19: 1821-1825; advance online publication, July 5, 2011; 10.1038/mt.2011.120

Abstract | Full Text

AAV-microdystrophin Therapy Improves Cardiac Performance in Aged Female mdx Mice

Brian Bostick, Jin-Hong Shin, Yongping Yue and Dongsheng Duan

Mol Ther 2011 19: 1826-1832; advance online publication, August 2, 2011; 10.1038/mt.2011.154

Abstract | Full Text

Expression of Apolipoprotein A-I in Rabbit Carotid Endothelium Protects Against Atherosclerosis

Rowan Flynn, Kun Qian, Chongren Tang, Nagadhara Dronadula, Joshua M Buckler, Bo Jiang, Shan Wen, Helén L Dichek and David A Dichek

Mol Ther 2011 19: 1833-1841; advance online publication, July 19, 2011; 10.1038/mt.2011.133

Abstract | Full Text

Large-volume Intrathecal Enzyme Delivery Increases Survival of a Mouse Model of Late Infantile Neuronal Ceroid Lipofuscinosis

Su Xu, Lingling Wang, Mukarram El-Banna, Istvan Sohar, David E Sleat and Peter Lobel

Mol Ther 2011 19: 1842-1848; advance online publication, July 5, 2011; 10.1038/mt.2011.130

Abstract | Full Text

A Cell-penetrating Peptide Suppresses Inflammation by Inhibiting NF-κB Signaling

Yu Fu Wang, Xiang Xu, Xia Fan, Chun Zhang, Qiang Wei, Xi Wang, Wei Guo, Wei Xing, Jian Yu, Jing-Long Yan and Hua-Ping Liang

Mol Ther 2011 19: 1849-1857; advance online publication, May 10, 2011; 10.1038/mt.2011.82

Abstract | Full Text

Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus

Ilkka Liikanen, Vladia Monsurrò, Laura Ahtiainen, Mari Raki, Tanja Hakkarainen, Iulia Diaconu, Sophie Escutenaire, Otto Hemminki, João D Dias, Vincenzo Cerullo, Anna Kanerva, Sari Pesonen, Daniela Marzioni, Marco Colombatti and Akseli Hemminki

Mol Ther 2011 19: 1858-1866; advance online publication, July 26, 2011; 10.1038/mt.2011.144

Abstract | Full Text

Correction of Murine SCID-X1 by Lentiviral Gene Therapy Using a Codon-optimized IL2RG Gene and Minimal Pretransplant Conditioning

Marshall W Huston, Niek P van Til, Trudi P Visser, Shazia Arshad, Martijn H Brugman, Claudia Cattoglio, Ali Nowrouzi, Yuedan Li, Axel Schambach, Manfred Schmidt, Christopher Baum, Christof von Kalle, Fulvio Mavilio, Fang Zhang, Mike P Blundell, Adrian J Thrasher, Monique MA Verstegen and Gerard Wagemaker

Mol Ther 2011 19: 1867-1877; advance online publication, July 12, 2011; 10.1038/mt.2011.127

Abstract | Full Text

Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide Aptamers

Fernando Pastor, Despina Kolonias, James O McNamara II and Eli Gilboa

Mol Ther 2011 19: 1878-1886; advance online publication, August 9, 2011; 10.1038/mt.2011.145

Abstract | Full Text

Alternative for Anti-TNF Antibodies for Arthritis Treatment

Joseph Paquet, Christel Henrionnet, Astrid Pinzano, Jean-Baptiste Vincourt, Pierre Gillet, Patrick Netter, Isabelle Chary-Valckenaere, Damien Loeuille, Jacques Pourel and Laurent Grossin

Mol Ther 2011 19: 1887-1895; advance online publication, August 2, 2011; 10.1038/mt.2011.156

Abstract | Full Text

Suppression of the Immune Response to FVIII in Hemophilia A Mice by Transgene Modified Tolerogenic Dendritic Cells

Rui-Jun Su, Angela Epp, Junli Feng, Jackie Roy, Yvette Latchman, Xiaoping Wu, Doug Bolgiano and Neil C Josephson

Mol Ther 2011 19: 1896-1904; advance online publication, July 19, 2011; 10.1038/mt.2011.134

Abstract | Full Text

Rapid and Efficient Generation of Functional Motor Neurons From Human Pluripotent Stem Cells Using Gene Delivered Transcription Factor Codes

Mark E Hester, Matthew J Murtha, SungWon Song, Meghan Rao, Carlos J Miranda, Kathrin Meyer, Jinbin Tian, Gabriella Boulting, David V Schaffer, Michael X Zhu, Samuel L Pfaff, Fred H Gage and Brian K Kaspar

Mol Ther 2011 19: 1905-1912; advance online publication, July 19, 2011; 10.1038/mt.2011.135

Abstract | Full Text

A Mechanistic Proof-of-concept Clinical Trial With JX-594, a Targeted Multi-mechanistic Oncolytic Poxvirus, in Patients With Metastatic Melanoma

Tae-Ho Hwang, Anne Moon, James Burke, Antoni Ribas, Joe Stephenson, Caroline J Breitbach, Manijeh Daneshmand, Naomi De Silva, Kelley Parato, Jean-Simon Diallo, Yeon-Sook Lee, Ta-Chiang Liu, John C Bell and David H Kirn

Mol Ther 2011 19: 1913-1922; advance online publication, July 19, 2011; 10.1038/mt.2011.132

Abstract | Full Text

Be part of the research that is changing the course of medicine!
Molecular Therapy
is the leading international journal for basic, translational and clinical research aimed at the development of novel cell and gene therapy approaches to treat disease.

To submit your research or view the complete Guide to Authors visit www.nature.com/mt/author_instructions.html
 

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Molecular Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: